RecruitingNot applicableNCT05582551

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Studying Neuromuscular disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Washington University School of Medicine
Principal Investigator
Robert J Hayashi, M.D.
Washington University School of Medicine
Intervention
Highlighting Patients at Risk for Sensory Screening (HPARSS)(other)
Enrollment
146 target
Eligibility
7-17 years · All sexes
Timeline
20232026

Study locations (1)

Collaborators

St. Jude Children's Research Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05582551 on ClinicalTrials.gov

Other trials for Neuromuscular disease

Additional recruiting or active studies for the same condition.

See all trials for Neuromuscular disease

← Back to all trials